The clonal nature of neoplastic lesions such as invasive breast cancer and
ductal carcinoma in situ (DCIS) has been widely proven by several prolifera
tive, genetic or other malignancy-associated markers. The aim of this study
is to clarify whether benign hyperplastic lesions such as ductal hyperplas
ia of usual type (DH) and papilloma can be distinguished from neoplastic le
sions such as DCIS by X-chromosome inactivation analysis. Clonal analysis w
as performed using a polymerase chain reaction-based assay for non-random X
-chromosome inactivation of the human androgen receptor gene (HUMARA). Form
alin-fixed and paraffin-embedded archival tissue of ten DCIS, sixteen DH, n
ine papillomas, and seven normal terminal ductal lobular units (TDLUs) was
laser-microdissected to avoid contamination with surrounding tissue. All of
the cases analysed revealed a monoclonal origin. Furthermore, in one of th
ese cases, opposite X chromosomes were inactivated within the same breast.
X-linked inactivation analysis clearly demonstrates that, at least in the b
reast, monoclonality is not restricted to neoplastic processes. The data su
pport the hypothesis that the mammary gland is organized into distinct stem
cell-derived monoclonal patches and that TDLUs are monoclonal in origin. A
ny proliferative lesion arising within such a pre-existing clonal patch sho
uld therefore be clonal, irrespective of whether it originates from one or
more patch cells. Thus, X-chromosome inactivation analysis cannot be consid
ered a valid I method far distinguishing between neoplastic and hyperplasti
c breast lesions. Copyright (C) 2000 John Wiley & Sons, Ltd.